Methicillin-Resistant Staphylococcus aureus: A Community Health Threat

References

• . Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532
   PubMed Web of Science ®Google Scholar
• . Pujol M, Peña C, Pallares R, . Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med. 1996;100(5):509–516
   PubMed Web of Science ®Google Scholar
• . Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96(1):11–16
   PubMed Web of Science ®Google Scholar
• . Moran GJ, Amii RN, Abrahamian FM, . Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infect Dis. 2005;11(6):928–930
   PubMed Web of Science ®Google Scholar
• . Kaplan SL, Hulten KG, Gonzalez BE, . Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785–1791
   PubMed Web of Science ®Google Scholar
• . Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45(3):311–320
   PubMed Web of Science ®Google Scholar
• . Young DM, Harris HW, Charlebois ED, . An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139(9):947–951
   PubMedGoogle Scholar
• . Minnesota Department of Health. Minnesota Department of Health Disease Control Newsletter. Community-associated methicillin-resistant Staphylococcus aureus in Minnesota. 2004;32:61–72
   Google Scholar
• . Ito T, Katayama Y, Asada K, . Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45(5):1323–1336
   PubMed Web of Science ®Google Scholar
• . Naimi TS, LeDell KH, Como-Sabetti K, . Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976–2984
   PubMed Web of Science ®Google Scholar
• . Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis. 2007;13(2):236–242
   PubMed Web of Science ®Google Scholar
• . McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41(11):5113–5120
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997–1999. JAMA. 1999;282(12):1123–1125
   PubMed Web of Science ®Google Scholar
• . Kennedy AD, Otto M, Braughton KR, . Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A. 2008;105(4):1327–1332
   PubMed Web of Science ®Google Scholar
• . Wang CC, Lo WT, Chu ML, Siu LK. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis. 2004;39(4):481–487
   PubMed Web of Science ®Google Scholar
• . Okuma K, Iwakawa K, Turnidge JD, . Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40(11):4289–4294
   PubMed Web of Science ®Google Scholar
• . Dufour P, Gillet Y, Bes M, . Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35(7):819–824
   PubMed Web of Science ®Google Scholar
• . Witte W, Braulke C, Cuny C, . Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis. 2005;24(1):1–5
   PubMed Web of Science ®Google Scholar
• . Witte W, Cuny C, Strommenger B, . Emergence of a new community acquired MRSA strain in Germany. Euro Surveill. 2004;9(1):16–18
   PubMedGoogle Scholar
• . Robinson DA, Kearns AM, Holmes A, . Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet. 2005;365:1256–1258
   PubMed Web of Science ®Google Scholar
• . Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41( suppl 4):S269–S272
   PubMed Web of Science ®Google Scholar
• . Eguia JM, Chambers HF. Community-acquired methicillin-resistant Staphylococcus aureus: epidemiology and potential virulence factors. Curr Infect Dis Rep. 2003;5(6):459–466
   PubMedGoogle Scholar
• . Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis. 2005;40(4):562–573
   PubMed Web of Science ®Google Scholar
• . Kazakova SV, Hageman JC, Matava M, . A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352(5):468–475
   PubMed Web of Science ®Google Scholar
• . Methicillin-resistant Staphylococcus aureus infection among competitive sports participants–Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. MMWR Morb Mort Wkly Rep. 2003;52(33):793–795
   PubMedGoogle Scholar
• . Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(5):752–760
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections–Los Angeles county, California, 2002–2003. MMWR Morb Mortal Wkly Rep. 2003;52:88
   Google Scholar
• . Zinderman CE, Conner B, Malakooti MA, . Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerging Infect Dis. 2004;10(5):941–944
   PubMed Web of Science ®Google Scholar
• . Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis. 2010;50(7):979–987
   PubMed Web of Science ®Google Scholar
• . Allen JE. Skin infection spreads among gay men in L.A. Los Angeles, CA: Los Angeles Times; 2003
   Google Scholar
• . Groom AV, Wolsey DH, Naimi TS, . Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286(10):1201–1205
   PubMed Web of Science ®Google Scholar
• . Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect. 1998;38(4):273–281
   PubMed Web of Science ®Google Scholar
• . Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007;33(4):45–48
   PubMedGoogle Scholar
• . Adcock PM, Pastor P, Medley F, . Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis. 1998;178(2):577–580
   PubMed Web of Science ®Google Scholar
• . Ragan P. Community-acquired MRSA infection: an update. JAAPA. 2006;19(4):24–29
   PubMedGoogle Scholar
• . Miller LG, Perdreau-Remington F, Bayer AS, . Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S aureus infection: a prospective investigation. Clin Infect Dis. 2007;44(4):471–482
   PubMed Web of Science ®Google Scholar
• . Moran GJ, Krishnadasan A, Gorwitz RJ, . EMERGEncy ID Net Study Group. Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–674
   PubMed Web of Science ®Google Scholar
• . Fridkin SK, Hageman JC, Morrison M, . Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436–1444
   PubMed Web of Science ®Google Scholar
• . Miller LG, Perdreau-Remington F, Rieg G, . Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445–1453
   PubMed Web of Science ®Google Scholar
• . Frazee BW, Lynn J, Charlebois ED, . High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45:311–20
   PubMed Web of Science ®Google Scholar
• . Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol. 2007;8(5):259–270
   PubMed Web of Science ®Google Scholar
• . Lee TC, Carrick MM, Scott BG, . Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. 2007;194(6):809–812
   PubMed Web of Science ®Google Scholar
• . Arnold SR, Elias D, Buckingham SC, . Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703–708
   PubMed Web of Science ®Google Scholar
• . Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, . Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23(8):701–706
   PubMed Web of Science ®Google Scholar
• . Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE, Hammerman WA, Kaplan SL. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006;117(2):433–440
   PubMed Web of Science ®Google Scholar
• . Boussaud V, Parrot A, Mayaud C, . Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med. 2003;29(10):1840–1843
   PubMed Web of Science ®Google Scholar
• . Hageman JC, Uyeki TM, Francis JS, . Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis. 2006;12(6):894–899
   PubMed Web of Science ®Google Scholar
• . Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza–Louisiana and Georgia, December 2006–January 2007. MMWR Morb Mortal Wkly Rep. 2007;56(14):325–329
   PubMedGoogle Scholar
• . Francis JS, Doherty MC, Lopatin U, . Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40(1):100–107
   PubMed Web of Science ®Google Scholar
• . Gonzalez BE, Martinez-Aguilar G, Hulten KG, . Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115(3):642–648
   PubMed Web of Science ®Google Scholar
• . Adem PV, Montgomery CP, Husain AN, . Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353(12):1245–1251
   PubMed Web of Science ®Google Scholar
• . Kravitz GR, Dries DJ, Peterson ML, . Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis. 2005;40(7):941–947
   PubMed Web of Science ®Google Scholar
• . Struelens MJ, Hawkey PM, French GL, Witte W, Tacconelli E. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect. 2009;15(2):112–129
   PubMed Web of Science ®Google Scholar
• . Liu C, Graber CJ, Karr M, . A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clin Infect Dis. 2008;46(11):1637–1646
   PubMed Web of Science ®Google Scholar
• . Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117(5):390–398
   PubMed Web of Science ®Google Scholar
• . Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51(2):423–428
   PubMed Web of Science ®Google Scholar
• . Cenizal MJ, Skiest D, Luber S, . Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51(7):2628–2630
   PubMed Web of Science ®Google Scholar
• . Crum NF, Lee RU, Thornton SA, . Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med. 2006;119(11):943–951
   PubMed Web of Science ®Google Scholar
• . Martínez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;22(7):593–598
   PubMed Web of Science ®Google Scholar
• . Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005;40(2):280–285
   PubMed Web of Science ®Google Scholar
• . Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006;193(11):1495–1503
   PubMed Web of Science ®Google Scholar
• . Han LL, McDougal LK, Gorwitz RJ, . High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol. 2007;45(4):1350–1352
   PubMed Web of Science ®Google Scholar
• . Nathwani D, Morgan M, Masterton RG, . Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother. 2008;61(5):976–994
   PubMed Web of Science ®Google Scholar
• . Howden BP, Grayson ML. Dumb and dumber–the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis. 2006;42(3):394–400
   PubMed Web of Science ®Google Scholar
• . Preventing the Spread of Vancomycin Resistance—A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting–CDC. Notice. Fed Regist. 1994;59(94):25758–25763
   PubMedGoogle Scholar
• . Iwamoto T, Kagawa Y, Kojima M. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull. 2003;26(6):876–879
   PubMed Web of Science ®Google Scholar
• . Howden BP. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA). Intern Med J. 2005;35( suppl 2):S136–S140
   Web of Science ®Google Scholar
• . Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother. 1996;37(2):209–222
   PubMed Web of Science ®Google Scholar
• . Sato M, Chida K, Suda T, . Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level. J Infect Chemother. 2006;12(4):185–189
   PubMedGoogle Scholar
• . Harding I, Macgowan AP, White LO, Darley ES, Reed V. Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome. J Antimicrob Chemother. 2000;45(6):835–841
   PubMed Web of Science ®Google Scholar
• . Yanagihara K, Kihara R, Araki N, . Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive methicillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection. Int J Antimicrob Agents. 2009;34(5):477–481
   PubMed Web of Science ®Google Scholar
• . Lee SY, Fan HW, Kuti JL, Nicolau DP. Update on daptomycin: the first approved lipopeptide antibiotic. Expert Opin Pharmacother. 2006;7(10):1381–1397
   PubMedGoogle Scholar
• . Marty FM, Yeh WW, Wennersten CB. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol. 2006;44(2):595–597
   PubMed Web of Science ®Google Scholar
• . Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195(2):202–211
   PubMed Web of Science ®Google Scholar